Combined HAT/EZH2 modulation leads to cancer-selective cell death.

about

Combined HAT/EZH2 modulation leads to cancer-selective cell death.

Item

http://www.wikidata.org/entity/Q55093017

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

Combined HAT/EZH2 modulation leads to cancer-selective cell death.

@en

Combined HAT/EZH2 modulation leads to cancer-selective cell death.

@nl

type

Item

label

Combined HAT/EZH2 modulation leads to cancer-selective cell death.

@en

Combined HAT/EZH2 modulation leads to cancer-selective cell death.

@nl

prefLabel

Combined HAT/EZH2 modulation leads to cancer-selective cell death.

@en

Combined HAT/EZH2 modulation leads to cancer-selective cell death.

@nl

P1476

Combined HAT/EZH2 modulation leads to cancer-selective cell death

@en

P2093

Abhishek A Singh

http://www.w3.org/2001/XMLSchema#string

Albertus T J Wierenga

http://www.w3.org/2001/XMLSchema#string

Alfonso Baldi

http://www.w3.org/2001/XMLSchema#string

Amit Mandoli

http://www.w3.org/2001/XMLSchema#string

Angela Nebbioso

http://www.w3.org/2001/XMLSchema#string

Antonello Mai

http://www.w3.org/2001/XMLSchema#string

Bowon Kim

http://www.w3.org/2001/XMLSchema#string

Colin Logie

http://www.w3.org/2001/XMLSchema#string

Concetta Ingenito

http://www.w3.org/2001/XMLSchema#string

Edo Vellenga

http://www.w3.org/2001/XMLSchema#string

P2860

Selective inhibition of BET bromodomains

The Cancer Genome Atlas Pan-Cancer analysis project

A decade of exploring the cancer epigenome - biological and translational implications

The SET-domain protein superfamily: protein lysine methyltransferases

Targeting histone methyltransferases and demethylases in clinical trials for cancer therapy

Trials with 'epigenetic' drugs: an update

Role of CHD5 in human cancers: 10 years later

Structure of the Catalytic Domain of EZH2 Reveals Conformational Plasticity in Cofactor and Substrate Binding Sites and Explains Oncogenic Mutations

Structural Context of Disease-Associated Mutations and Putative Mechanism of Autoinhibition Revealed by X-Ray Crystallographic Analysis of the EZH2-SET Domain

Genomic Classification and Prognosis in Acute Myeloid Leukemia.

P304

25630-25646

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.18632/ONCOTARGET.25428

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

P577

2018-05-22T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29876013

http://www.w3.org/2001/XMLSchema#string

P932

5986654

http://www.w3.org/2001/XMLSchema#string